Article Text

Download PDFPDF

A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia
  1. Alice Fabbri1,2,
  2. Quinn Grundy2,
  3. Barbara Mintzes2,
  4. Swestika Swandari2,
  5. Ray Moynihan3,4,
  6. Emily Walkom5,
  7. Lisa A Bero2
  1. 1 Center of Research in Medical Pharmacology, The University of Insubria, Varese, Italy
  2. 2 Charles Perkins Centre and Faculty of Pharmacy, The University of Sydney, Camperdown, Australia
  3. 3 Faculty of Health Sciences and Medicine, Bond University, Robina, Australia
  4. 4 Sydney Medical School – Public Health, The University of Sydney, Camperdown, Australia
  5. 5 School of Medicine and Public Health, University of Newcastle, Newcastle, Australia
  1. Correspondence to Dr Lisa A Bero; lisa.bero{at}sydney.edu.au

Abstract

Objectives To analyse patterns and characteristics of pharmaceutical industry sponsorship of events for Australian health professionals and to understand the implications of recent changes in transparency provisions that no longer require reporting of payments for food and beverages.

Design Cross-sectional analysis.

Participants and setting 301 publicly available company transparency reports downloaded from the website of Medicines Australia, the pharmaceutical industry trade association, covering the period from October 2011 to September 2015.

Results Forty-two companies sponsored 116 845 events for health professionals, on average 608 per week with 30 attendees per event. Events typically included a broad range of health professionals: 82.0% included medical doctors, including specialists and primary care doctors, and 38.3% trainees. Oncology, surgery and endocrinology were the most frequent clinical areas of focus. Most events (64.2%) were held in a clinical setting. The median cost per event was $A263 (IQR $A153–1195) and over 90% included food and beverages.

Conclusions Over this 4-year period, industry-sponsored events were widespread and pharmaceutical companies maintained a high frequency of contact with health professionals. Most events were held in clinical settings, suggesting a pervasive commercial presence in everyday clinical practice. Food and beverages, known to be associated with changes to prescribing practice, were almost always provided. New Australian transparency provisions explicitly exclude meals from the reporting requirements; thus, a large proportion of potentially influential payments from pharmaceutical companies to health professionals will disappear from public view.

  • health policy
  • public health
  • education & training (see medical education &training)

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors AF, QG, BM, RM, LAB conceived of the study. AF, QG, BM, RM, EW designed the coding scheme. AF, QG and SS acquired and analysed all data. AF drafted the manuscript. All the authors contributed to the writing of the paper and approved the final version. AF is the guarantor.

  • Funding The work was partially funded via a University of Sydney Faculty of Pharmacy summer scholarship.

  • Competing interests All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author). BM reports that she was an expert witness on behalf of plaintiffs in a Canadian class action suit concerning cardiovascular risks of a testosterone gel. None of the authors received any payments, funding or other financial support from pharmaceutical manufacturers. The authors declare no other relationships or activities that could appear to have influenced the submitted work

  • Patient consent The study did not involve patients.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement The analysable dataset in CSV file format is available at:http://dx.doi.org/10.4227/11/592631edbd9d5

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.